BRSF (Brain Scientific) 5-Year EBITDA Growth Rate: 0.00% (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BRSF Brain Scientific Inc BRSF
10 GF Score
Price $0.00
View Full Analysis

What is Brain Scientific 5-Year EBITDA Growth Rate?

Brain Scientific BRSF 10 5-Year EBITDA Growth Rate is 0.00% as of Dec. 2022. GuruFocus rates BRSF with a GF Score™ of 10/100.

Brain Scientific's EBITDA per Share for the three months ended in Dec. 2022 was $-0.08.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Brain Scientific  (OTCPK:BRSF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Brain Scientific 5-Year EBITDA Growth Rate Related Terms

BRSF vs MOTS, BRSF, PBIO: 5-Year EBITDA Growth Rate Comparison

For the Medical Devices subindustry, Brain Scientific's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brain Scientific 5-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Brain Scientific's 5-Year EBITDA Growth Rate falls into.


BRSF
10GF Score
Brain Scientific Inc BRSF
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brain Scientific 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Brain Scientific (BRSF) has a 5-Year EBITDA Growth Rate of 0.00% as of Dec. 2022. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Brain Scientific and its competitors.
Is Brain Scientific's 5-Year EBITDA Growth Rate too high?
Brain Scientific's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Brain Scientific has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Brain Scientific's 5-Year EBITDA Growth Rate compare to MOTS and BRSF?
Brain Scientific's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
A good 5-Year EBITDA Growth Rate depends on the Medical Devices & Instruments industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Brain Scientific and its competitors. Brain Scientific's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brain Scientific stock overvalued right now?
Brain Scientific (BRSF) has a current 5-Year EBITDA Growth Rate of 0.00%. The current 5-Year EBITDA Growth Rate is 0.00%. Brain Scientific's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Brain Scientific (BRSF), the current 5-Year EBITDA Growth Rate is 0.00% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brain Scientific Business Description

Address 6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
10GF Score

Get the complete analysis for BRSF

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price